DNA methylation in schizophrenia in different patient-derived cell types

Epigenetics: A genome-wide picture in patient-derived cells Schizophrenia-associated differences in the DNA methylation status of patient-derived cells suggest it could affect early brain development. Mechanisms that control gene expression without altering the genetic code, such as DNA methylation,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alejandra M. Vitale, Nicholas A. Matigian, Alexandre S. Cristino, Katia Nones, Sugandha Ravishankar, Bernadette Bellette, Yongjun Fan, Stephen A. Wood, Ernst Wolvetang, Alan Mackay-Sim
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Acceso en línea:https://doaj.org/article/5b0cc3f9768c4ac98732fd625650c1cb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5b0cc3f9768c4ac98732fd625650c1cb
record_format dspace
spelling oai:doaj.org-article:5b0cc3f9768c4ac98732fd625650c1cb2021-12-02T15:18:48ZDNA methylation in schizophrenia in different patient-derived cell types10.1038/s41537-016-0006-02334-265Xhttps://doaj.org/article/5b0cc3f9768c4ac98732fd625650c1cb2017-01-01T00:00:00Zhttps://doi.org/10.1038/s41537-016-0006-0https://doaj.org/toc/2334-265XEpigenetics: A genome-wide picture in patient-derived cells Schizophrenia-associated differences in the DNA methylation status of patient-derived cells suggest it could affect early brain development. Mechanisms that control gene expression without altering the genetic code, such as DNA methylation, could explain how environmental risk factors contribute to schizophrenia in genetically susceptible individuals. Alan Mackay-Sim and colleagues from Griffith University, Australia, carried out genome-wide comparisons of DNA methylation in induced pluripotent stem (iPS) cells, olfactory neurosphere-derived cells and fibroblasts from patients and controls. Differences in the DNA methylation pattern between patient and control iPS cells, which could reflect what happens in the embryo, suggest a disease-associated effect very early on in development. Only five genes were differentially methylated in all three patient-derived cell types compared to controls. None of these genes has previously been associated with schizophrenia and may represent new targets for future research.Alejandra M. VitaleNicholas A. MatigianAlexandre S. CristinoKatia NonesSugandha RavishankarBernadette BelletteYongjun FanStephen A. WoodErnst WolvetangAlan Mackay-SimNature PortfolioarticlePsychiatryRC435-571ENnpj Schizophrenia, Vol 3, Iss 1, Pp 1-11 (2017)
institution DOAJ
collection DOAJ
language EN
topic Psychiatry
RC435-571
spellingShingle Psychiatry
RC435-571
Alejandra M. Vitale
Nicholas A. Matigian
Alexandre S. Cristino
Katia Nones
Sugandha Ravishankar
Bernadette Bellette
Yongjun Fan
Stephen A. Wood
Ernst Wolvetang
Alan Mackay-Sim
DNA methylation in schizophrenia in different patient-derived cell types
description Epigenetics: A genome-wide picture in patient-derived cells Schizophrenia-associated differences in the DNA methylation status of patient-derived cells suggest it could affect early brain development. Mechanisms that control gene expression without altering the genetic code, such as DNA methylation, could explain how environmental risk factors contribute to schizophrenia in genetically susceptible individuals. Alan Mackay-Sim and colleagues from Griffith University, Australia, carried out genome-wide comparisons of DNA methylation in induced pluripotent stem (iPS) cells, olfactory neurosphere-derived cells and fibroblasts from patients and controls. Differences in the DNA methylation pattern between patient and control iPS cells, which could reflect what happens in the embryo, suggest a disease-associated effect very early on in development. Only five genes were differentially methylated in all three patient-derived cell types compared to controls. None of these genes has previously been associated with schizophrenia and may represent new targets for future research.
format article
author Alejandra M. Vitale
Nicholas A. Matigian
Alexandre S. Cristino
Katia Nones
Sugandha Ravishankar
Bernadette Bellette
Yongjun Fan
Stephen A. Wood
Ernst Wolvetang
Alan Mackay-Sim
author_facet Alejandra M. Vitale
Nicholas A. Matigian
Alexandre S. Cristino
Katia Nones
Sugandha Ravishankar
Bernadette Bellette
Yongjun Fan
Stephen A. Wood
Ernst Wolvetang
Alan Mackay-Sim
author_sort Alejandra M. Vitale
title DNA methylation in schizophrenia in different patient-derived cell types
title_short DNA methylation in schizophrenia in different patient-derived cell types
title_full DNA methylation in schizophrenia in different patient-derived cell types
title_fullStr DNA methylation in schizophrenia in different patient-derived cell types
title_full_unstemmed DNA methylation in schizophrenia in different patient-derived cell types
title_sort dna methylation in schizophrenia in different patient-derived cell types
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/5b0cc3f9768c4ac98732fd625650c1cb
work_keys_str_mv AT alejandramvitale dnamethylationinschizophreniaindifferentpatientderivedcelltypes
AT nicholasamatigian dnamethylationinschizophreniaindifferentpatientderivedcelltypes
AT alexandrescristino dnamethylationinschizophreniaindifferentpatientderivedcelltypes
AT katianones dnamethylationinschizophreniaindifferentpatientderivedcelltypes
AT sugandharavishankar dnamethylationinschizophreniaindifferentpatientderivedcelltypes
AT bernadettebellette dnamethylationinschizophreniaindifferentpatientderivedcelltypes
AT yongjunfan dnamethylationinschizophreniaindifferentpatientderivedcelltypes
AT stephenawood dnamethylationinschizophreniaindifferentpatientderivedcelltypes
AT ernstwolvetang dnamethylationinschizophreniaindifferentpatientderivedcelltypes
AT alanmackaysim dnamethylationinschizophreniaindifferentpatientderivedcelltypes
_version_ 1718387446993911808